Phase 4 N=41 Randomized Triple-blind Treatment

Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis

Interstitial Cystitis

Bottom Line

View on ClinicalTrials.gov: NCT01195116 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2015

Primary outcome: Primary: Change in Pain Score (1-10, 10 is Most Pain) From Baseline, to Average Post op Pain Score in PACU — -1.46; -.025 units on a scale

Study Design & Population

Study type: Interventional
Phase: Phase 4
Interventions: Dexmedetomidine (Drug); Normal Saline (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Rochester
Primary completion: Apr 2012

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Pain Score (1-10, 10 is Most Pain) From Baseline, to Average Post op Pain Score in PACU	-1.46; -.025	—

Summary

The purpose of this study is to assess the effects of dexmedetomidine while patients undergo treatment for Interstitial Cystitis (IC). The investigators goal is to demonstrate in patients with IC undergoing bladder hydrodistension that the use of dexmedetomidine as a supplemental anesthetic agent will result in better postoperative pain management.

Eligibility Criteria

Inclusion Criteria

Patients with a clinical diagnosis of IC scheduled for cystoscopy and hydrodistension for both diagnostic and therapeutic indications.
2. Gender of Patients: Male & female,Age of Patients: 18 and older

Exclusion Criteria

Conduction disturbance (second degree AV block or greater), or previous reaction to medications used in this study. Patients receiving spinal anesthesia will not be included.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01195116). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.